Get started
Author

Anmol Seelan

Observed name: Seelan, Anmol
ORCID: 0009-0008-2799-3328
Observed ORCID: 0009-0008-2799-3328
OpenAlex ID: A5093977827
Unveiling Green Synthesis and Biomedical Theranostic paradigms of Selenium Nanoparticles (SeNPs) - A state-of-the-art comprehensive update
2024 · Sagnik Nag, Shinjini Kar, et al. · International Journal of Pharmaceutics · 65
Harnessing the foundation of biomedical waste management for fostering public health: strategies and policies for a clean and safer environment
2024 · Harpreet Singh, Kamal YT, et al. · Discover Applied Sciences · 47
PDF
Molecular targeted therapies for cutaneous squamous cell carcinoma: recent developments and clinical implications
2023 · Singh, Harpreet, Chopra, Hitesh, et al. · EXCLI journal · 7
PDF
Programmable spatiotemporal control of CRISPR-Cas12a: Engineering precision for next-generation gene editing and diagnostics
2026 · Anmol Seelan, Labdhi Shah, et al. · Synthetic and Systems Biotechnology · 5
Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments – a state-of-the-art update
2025 · Neevashini Chengebroyen, Anmol Seelan, et al. · Frontiers in Pharmacology · 3
PDF
Correction: Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments – a state-of-the-art update
2025 · Neevashini Chengebroyen, Anmol Seelan, et al. · Frontiers in Pharmacology
PDF
Immune System Modulation by Probiotics: An Account of Brain Cancers
2025 · Shruti Ghumra, Anmol Seelan, et al. · Apple Academic Press eBooks
Works count: 7
Citation count: 127
H-index: 4
I10-index: 2
Year
Topic
Type